Nuclear Imaging of Cancer Cell Therapies
Overview
Authors
Affiliations
A promising role of cellular therapies in cancer treatment is reflected by the constantly growing number of clinical trials with adoptively transferred cells. Direct and indirect cell labeling for the nuclear imaging of transferred cells has been proven reliable for imaging adoptive cellular therapies. Both methods show their advantages and limitations. Direct labeling is a relatively easy, inexpensive, and well-established methodology. Indirect labeling using a reporter gene imaging paradigm allows for reliable, stable, and harmless visualization of cellular trafficking, persistence, proliferation, and function at the target site. It is expected that new human-derived reporter genes will be rapidly translated into clinical applications that require repetitive imaging for the effective monitoring of various genetic and cellular therapies.
Li X, Yin G, Ji W, Liu J, Zhang Y, Wang J Onco Targets Ther. 2020; 13:11659-11668.
PMID: 33223839 PMC: 7671474. DOI: 10.2147/OTT.S271657.
Mathew B, Schmitz A, Munoz-Descalzo S, Ansari N, Pampaloni F, Stelzer E BMC Bioinformatics. 2015; 16:187.
PMID: 26049713 PMC: 4458345. DOI: 10.1186/s12859-015-0617-x.
Park J, Lee T, Son J, Chun K, Song I, Park Y Cancer Biother Radiopharm. 2012; 27(10):719-28.
PMID: 23009582 PMC: 3516418. DOI: 10.1089/cbr.2012.1225.
Wang Y, Zhang W, Hu S, Lan F, Lee A, Huber B Circ Res. 2012; 111(12):1494-503.
PMID: 22967807 PMC: 3518748. DOI: 10.1161/CIRCRESAHA.112.274969.
Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation.
Cai W, Zhang Y, Kamp T Am J Nucl Med Mol Imaging. 2011; 1(1):18-28.
PMID: 21841970 PMC: 3155258.